Acknowledgement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. RS-2023-00208882, No. NRF-2022M3J6A1063595). This research was also supported and funded by the Korean National Police Agency [Project Name: Advancing the Appraisal Techniques of Forensic Entomology / Project Number: PR10-04-000-22].
References
- Brunner E, Bathke AC, and Konietschke F (2018). Rank and Pseudo-rank Procedures for Independent Observations in Factorial Designs, Springer International Publishing, Cham, Switzerland.
- Brunner E, Konietschke F, Bathke AC, and Pauly M (2021). Ranks and Pseudo-ranks-Surprising results of certain rank tests in unbalanced designs, International Statistical Review, 89, 349-366.
- Brunner E and Puri ML (1996). 19 nonparametric methods in design and analysis of experiments, Handbook of Statistics, 13, 631-703.
- Domhof S (2001). Nichtparametrische relative Effekte (Ph D. thesis), University of Gottingen, Gotting en.
- Guideline IHT (2000). Choice of control group and related issues in clinical trials E10. Choice. E, 10, Available from: www.ich.org/fileadmin/Public Web Site/ICH Products/Guidelines/Efficacy/E10/Step4/E10 Guideline.pdf
- Hida E and Tango T (2011). On the three-arm non-inferiority trial including a placebo with a prespecified margin, Statistics in Medicine, 30, 224-231.
- Huang LC, Wen MJ, and Cheung SH (2015). Noninferiority studies with multiple new treatments and heterogeneous variances, Journal of Biopharmaceutical Statistics, 25, 958-971.
- Munzel U (2009). Nonparametric non-inferiority analyses in the three-arm design with active control and placebo, Statistics in Medicine, 28, 3643-3656.
- Park S and Kim D (2014). Nonparametric method for a non-inferiority test using confidence interval, The Korean Journal of Applied Statistics, 27, 833-842.
- U.S. Food and Drug Administration (2016). Non-inferiority clinical trials to establish effectiveness - guidance for industry, FDA guidance for industry, Available from: www.fda.gov/regulatoryinformation/search-fda-guidancedocuments/non-inferiority-clinical-trials-establish-effectivenessguidance-industry